Genetic screening for cancer
Genomic Testing for Cancer
Genomic sequencing is a powerful tool when it comes to treating cancer. Genomic tests guide the development of customized treatments based on each patient’s unique genetic makeup and cancer cell mutations.
Florida Cancer Specialists & Research Institute (FCS) has robust genetic testing capabilities available for patients.
DNA Sequencing for Targeted Therapy
Our state-of-the-art FCS Laboratory is equipped to provide next-generation sequencing (NGS) clinical testing for solid tumors, hematologic malignancies, and liquid biopsies. Information gained through genomic testing can be used to personalize therapy — increasing cure rates and extending lives.
NGS testing allows geneticists to detect mutations in hundreds of different genes simultaneously, giving a more unique understanding of each patient’s individual diagnosis. When oncologists know the specific genetic alteration a patient has, there may be a therapy that actually targets that exact mutation, as well as ongoing clinical trials the patient would be eligible for based on his/her molecular profile.
FCS continues to expand our robust in-house testing capabilities to provide our patients with fast, accurate diagnoses and treatment planning, leading to more positive outcomes.
Genetic Testing for Hereditary Cancer Risk
We can inherit genetic mutations from our parents that put us at increased risk of developing certain cancers. Knowing risk factors for hereditary cancers early can be lifesaving, allowing patients to choose early screening and preventative treatments to decrease their risk of disease.
Supported by the latest technology, hereditary genetic tests help to identify those who are at high-risk. Individuals can be referred for consultation and hereditary genetic testing or receive guidance to make lifestyle changes or explore other preventive options to reduce future risk.